News
Kiniksa Pharmaceuticals surpasses Q1 expectations, raises ARCALYST sales guidance. Read the latest earnings review here on ...
Beam Therapeutics and Verve Therapeutics have each built their lead candidates on a technique billed as a safer alternative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback